{"id":"NCT00371683","sponsor":"Bristol-Myers Squibb","briefTitle":"Study of Apixaban for the Prevention of Thrombosis-related Events Following Knee Replacement Surgery","officialTitle":"A Phase 3 Randomized, Double-Blind Active-Controlled (Enoxaparin), Parallel-Group, Multi-Center Study to Evaluate the Safety and Efficacy of Oral Apixaban in Subjects Undergoing Elective Total Knee Replacement Surgery","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-11","primaryCompletion":"2008-05","completion":"2008-05","firstPosted":"2006-09-04","resultsPosted":"2015-12-30","lastUpdate":"2015-12-30"},"enrollment":3608,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["Deep Vein Thrombosis","Pulmonary Embolism"],"interventions":[{"type":"DRUG","name":"Enoxaparin + Placebo","otherNames":["Lovenox®"]},{"type":"DRUG","name":"Apixaban + Placebo","otherNames":[]}],"arms":[{"label":"A1","type":"ACTIVE_COMPARATOR"},{"label":"A2","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to learn if apixaban can prevent blood clots in the leg (deep vein Thrombosis \\[DVT\\]) and lung (pulmonary embolism \\[PE\\]) that sometimes occur after knee replacement surgery and to learn how apixaban compares to enoxaparin (Lovenox®) for preventing these clots. The safety of apixaban will also be studied.","primaryOutcome":{"measure":"Event Rate of the Composite of Adjudicated Venous Thromboembolism (VTE) Events and All-Cause Death With Onset During the Intended Treatment Period - Primary Subjects","timeFrame":"From Day 1 or Day 2 to last dose, plus 2 days or 14 days post randomization","effectByArm":[{"arm":"Apixaban 2.5mg BID","deltaMin":8.99,"sd":null},{"arm":"Enoxaparin 30 mg SC Injection q 12 Hours","deltaMin":8.85,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0635"},{"comp":"OG000 vs OG001","p":"<0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":5},"locations":{"siteCount":107,"countries":["United States","Argentina","Australia","Brazil","Canada","Denmark","Hungary","Israel","Mexico","Poland","Russia","Sweden","Turkey (Türkiye)"]},"refs":{"pmids":["35570249","19657123"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":123,"n":1596},"commonTop":["Constipation","Nausea","Pyrexia","Oedema peripheral","Deep vein thrombosis"]}}